Virginia Retirement Systems Et Al Gilead Sciences, Inc. Transaction History

Virginia Retirement Systems Et Al

$15 Billion
Q3 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 1,281,395 shares of GILD stock, worth $153 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

1,281,395

Previous 1,277,495 0.31%

Holding current value

$153 Million

Previous $142 Million 0.42%

% of portfolio

0.95%

Previous 0.99%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$108.22 - $120.47 $422,058 - $469,833	3,900 Added 0.31%	1,281,395 $142 Million
Q1 2025 Jul 16, 2025	SELL	$89.14 - $117.41 $5.81 Million - $7.66 Million	-65,200 Reduced 4.86%	1,277,495 $143 Million
Q3 2023 Jan 02, 2024	BUY	$73.94 - $80.67 $5.89 Million - $6.42 Million	79,600 Added 6.3%	1,342,695 $101 Million
Q2 2023 Aug 22, 2023	BUY	$76.01 - $86.7 $2.93 Million - $3.35 Million	38,600 Added 3.15%	1,263,095 $97.3 Million
Q1 2023 Jul 11, 2023	BUY	$77.31 - $88.08 $25.6 Million - $29.2 Million	331,195 Added 37.08%	1,224,495 $102 Million
Q4 2022 May 17, 2023	BUY	$62.32 - $89.47 $13.3 Million - $19.1 Million	213,200 Added 31.35%	893,300 $76.7 Billion
Q3 2022 May 16, 2023	BUY	$59.54 - $68.01 $40.5 Million - $46.3 Million	680,100 New	680,100 $42 Billion
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $6.94 Million - $7.59 Million	-109,400 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $6.56 Million - $7.49 Million	109,400 New	109,400 $7.07 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $12.6 Million - $14.4 Million	-223,200 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $6.41 Million - $8.07 Million	-103,300 Reduced 31.64%	223,200 $14.1 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $18.8 Million - $21.8 Million	260,000 Added 390.98%	326,500 $25.1 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $4.16 Million - $5.33 Million	66,500 New	66,500 $4.97 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $6.47 Million - $7.12 Million	-105,000 Closed	0 $0
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $1.66 Million - $1.84 Million	-26,600 Reduced 20.21%	105,000 $6.66 Million
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $3.22 Million - $3.61 Million	52,000 Added 65.33%	131,600 $8.89 Million
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $6.05 Million - $6.78 Million	-96,800 Reduced 54.88%	79,600 $5.18 Million
Q4 2018 Feb 07, 2019	BUY	$60.54 - $79.0 $6.88 Million - $8.98 Million	113,700 Added 181.34%	176,400 $11 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $4.07 Million - $4.75 Million	62,700 New	62,700 $4.44 Million

Others Institutions Holding GILD

# of Institutions

2,347

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Gilead Sciences, Inc. Transaction History